Brief: Adaptive Biotechnologies Q3 EPS USD -0.22
07/11/2024 21:05
Nov 07 (Reuters) - Adaptive Biotechnologies Q3 revenue USD 46.435 million vs. IBES estimate USD 40.2 million. * Q3 operating income USD -32.632 million vs. IBES estimate USD -43.2 million * Q3 net income USD -32.097 million vs. IBES estimate USD -43.9 million * Q3 operating expenses USD 79.067 million * Q3 adjusted EBITDA USD -14.3 million vs. IBES estimate USD -23.6 million
Recent news on Adaptive Biotechnologies
See all newsAdvisory: Alert incorrectly tagged to Adaptive Biotechnologies withdrawn
U.S. RESEARCH ROUNDUP-Cloudflare, Replimune, Walmart
U.S. RESEARCH ROUNDUP-Equinix, Meta, S&P Global
Adaptive Biotechnologies Corp reports results for the quarter ended June 30 - Earnings Summary
Adaptive Biotechnologies Q2 revenue rises 22%, beats estimates